Catherine Owen Adams Succeeds Steve Davis as CEO of Acadia Pharmaceuticals
– Ms. Owen Adams brings over 25 years of pharmaceutical industry experience including senior commercial leadership roles with Bristol Myers Squibb and Johnson & Johnson SAN DIEGO, Sep. 23, 2024 – Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that Catherine Owen Adams has succeeded Steve Davis as Chief Executive Officer (CEO) and joined the Acadia Board of Directors. “We are excited to welcome Catherine Owen … Continue reading Catherine Owen Adams Succeeds Steve Davis as CEO of Acadia Pharmaceuticals